Corporate News     25-Oct-24 Board of Bharat Petroleum Corporation defers rights issue At meeting held on 25 October 2024 The Board of Bharat Petroleum Corporation at its meeting held on 25 October 2024 has decided not to pursue raising of Capital through Rights Issue owing to improved internal generation of funds and also the communication received from MoP&NG regarding non allocation of funds for capital support of Oil Marketing Companies (OMCs) in the budget 2024-25 and hence Government of India's non participation in the issue. Previous News   Benchmarks near day's high; media shares rally for 7th day  ( Market Commentary - Mid-Session 03-Dec-24   11:30 )   BPCL inks pact with Coal India  ( Hot Pursuit - 03-Dec-24   10:05 )   Bharat Petroleum Corporation and Coal India signs MoU  ( Corporate News - 02-Dec-24   18:27 )   Bharat Petroleum Corporation announces cessation of directors  ( Corporate News - 12-Nov-24   13:17 )   Bharat Petroleum Corporation  ( Results - Analysis 26-Oct-24   10:38 )   Bharat Petroleum Corporation consolidated net profit declines 72.13% in the September 2024 quarter  ( Results - Announcements 25-Oct-24   18:36 )   Bharat Petroleum Corporation standalone net profit declines 71.80% in the September 2024 quarter  ( Results - Announcements 25-Oct-24   18:33 )   BPCL tanks as Q2 PAT slumps 72% YoY to Rs 2,397 cr  ( Hot Pursuit - 25-Oct-24   16:43 )   Board of Bharat Petroleum Corporation defers rights issue  ( Corporate News - 25-Oct-24   15:48 )   Bharat Petroleum Corporation to convene board meeting  ( Corporate News - 17-Oct-24   12:57 )   Bharat Petroleum Corporation Ltd up for third straight session  ( Hot Pursuit - 15-Oct-24   13:05 )	Other Stories   Ipca Laboratories to voluntarily close its wholly owned subsidiary in Mexico   04-Dec-24   16:57   Sonata Software achieves AWS Generative AI Competency   04-Dec-24   16:56   Nuvama Wealth Management allots 10,256 equity shares under ESOS   04-Dec-24   16:54   IndiaMART Intermesh allots 53,000 equity shares under ESOP   04-Dec-24   16:45   Alembic Pharma receives USFDA's tentative approval for Olopatadine Hydrochloride Ophthalmic Solution   04-Dec-24   16:41   Uno Minda announces change in senior management   04-Dec-24   16:40   Cyient allots 26,604 equity shares under ASOP   04-Dec-24   16:39   Mphasis inaugurates new Cyber Fusion Center in Bangalore   04-Dec-24   16:18   Hero MotoCorp launches VIDA V2 range of electric scooters   04-Dec-24   16:13   Mastek announces resignation of Global CFO   04-Dec-24   16:10
Back Top